VascVersa raises 500k pounds in seed round for developing a cell therapy product
Belfast Telegraph - 09-Aug-2022VascVersa is committed to regenerative medicine for people suffering from ischaemic diseases
VascVersa
Regenerative Medicine company recently spun out from Queen's University in Belfast
VascVersa Ltd is a Regenerative Medicine Company developing exciting new cell therapies that promote vascular regeneration and repair.
VascVersa is new Regenerative Medicine company recently spun out from Queen's University in Belfast. Our Vision is to commercialise living medicines to reinvigorate patients lives. Utilising Angicyte technology we are developing new cell therapies for vascular regeneration.
At VascVersa, they are committed to developing innovative regenerative medicine, to deliver a profound improvement to the lives of many individuals suffering from debilitating ischaemic diseases. In doing so we will address the urgent need for new treatments to repair damaged blood vessels and revitalise tissue.
Visit website: https://www.vascversa.org/
Details last updated 10-Aug-2022
VascVersa News
People at VascVersa
